Biovie Inc (BIVI)

Biovie Inc (BIVI) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $11.9M; returns 1 day -3.1%, 1 week +3.3%, 1 year -34.4%.

BioVie Inc. (BIVI) is a clinical-stage biopharmaceutical company focused on developing innovative drug therapies for neurological, neurodegenerative disorders, and advanced liver disease. Their lead drug candidate, bezisterim (NE3107), aims to reduce neuroinflammation and insulin resistance, targeting Alzheimer's and Parkinson's diseases.

Groups BIVI belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage
• Clinical Stage Biotech
• Neurological Disorders
• Alzheimer's Disease
• Neuroscience
• Liver Disease
• Healthcare
• CNS Disorders
• Life Sciences

BIVI financial model: income statement, cash flow and balance sheet